China NMPA Product Recall - Diagnostic Ultrasound System

On December 1, 2021, GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its Diagnostic Ultrasound System (Registration Certificate No.: 国械注进20192060366). This action, reported by the Shanghai Municipal Drug Administration and the National Medical Products Administration (NMPA), addresses a critical product performance issue. The primary concern identified is the system's failure to power on, attributed to a depleted internal battery. This malfunction directly impacts the device's operational readiness and reliability, posing a potential disruption to diagnostic procedures. The recall encompasses specific models, specifications, and batch numbers of the affected product, detailed in an accompanying "Medical Device Recall Event Report Form." A Class II recall signifies a situation where the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. GE Healthcare is undertaking this proactive measure to ensure product safety and compliance with regulatory standards set by the NMPA, reinforcing their commitment to quality and patient care. This voluntary recall highlights the company's responsibility in rectifying product deficiencies and maintaining public trust in medical devices.